(a)in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b)paragraph 2(c) is replaced by the following:
(c)shall not exceed the following:
(i)EUR 4600000 for Spain;
(ii)EUR 3000000 for Italy;
(iii)EUR 90000 for Cyprus;
(iv)EUR 1040000 for Portugal;
(v)EUR 1350000 for the United Kingdom.’;
(c)in paragraph 3, points (a) to (d) are replaced by the following:‘(a)for a rose bengal testEUR 0,24 per test;(b)for a SAT testEUR 0,24 per test;(c)for a complement fixation testEUR 0,48 per test;(d)for an ELISA testEUR 1,2 per test’;
10.in Article 10 paragraph 4, ‘paragraphs 2 and 3’ is replaced by ‘paragraph 2(a), paragraph 2(b) and paragraph 3’;
11.Article 11, paragraph 5(c) is amended as follows:
(a)in point (i) ‘EUR 2250000’ is replaced by ‘EUR 1600000’;
(b)in point (ii) ‘EUR 1800000’ is replaced by ‘EUR 1500000’;
(c)in point (v) ‘EUR 740000’ is replaced by ‘EUR 850000’;
12.in Article 11 paragraph 7, ‘paragraphs 5 and 6’ is replaced by ‘paragraph 5(a), paragraph 5(b) and paragraph 6’.
(a)in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b)paragraph 2(c) is replaced by the following:
(c)shall not exceed the following:
(i)EUR 16000000 for Ireland;
(ii)EUR 18500000 for Spain;
(iii)EUR 5500000 for Italy;
(iv)EUR 1440000 for Portugal;
(v)EUR 26500000 for the United Kingdom.’;
(c)in paragraph 3, points (a) and (b) are replaced by the following:‘(a)for a tuberculin testEUR 2,4 per test;(b)for a gamma-interferon testEUR 6 per test’;
(a)in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b)paragraph 2(c) is replaced by the following:
(c)shall not exceed the following:
(i)EUR 160000 for Greece;
(ii)EUR 9200000 for Spain;
(iii)EUR 4200000 for Italy;
(iv)EUR 85000 for Cyprus;
(v)EUR 2260000 for Portugal.’;
(c)in paragraph 3, points (a) and (b) are replaced by the following:‘(a)for a rose bengal testEUR 0,24 per test;(b)for a complement fixation testEUR 0,48 per test;’;
(a)in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b)paragraph 2(c) is replaced by the following:
(c)shall not exceed the following:
(i)EUR 420000 for Belgium;
(ii)EUR 10000 for Bulgaria;
(iii)EUR 1700000 for the Czech Republic;
(iv)EUR 0 for Denmark;
(v)EUR 400000 for Germany;
(vi)EUR 10000 for Estonia;
(vii)EUR 10000 for Ireland;
(viii)EUR 100000 for Greece;
(ix)EUR 5200000 for Spain;
(x)EUR 3000000 for France;
(xi)EUR 300000 for Italy;
(xii)EUR 20000 for Latvia;
(xiii)EUR 5000 for Lithuania;
(xiv)EUR 60000 for Hungary;
(xv)EUR 10000 for Malta;
(xvi)EUR 50000 for the Netherlands;
(xvii)EUR 160000 for Austria;
(xviii)EUR 50000 for Poland;
(xix)EUR 1650000 for Portugal;
(xx)EUR 100000 for Romania;
(xxi)EUR 50000 for Slovenia;
(xxii)EUR 60000 for Slovakia;
(xxiii)EUR 20000 for Finland;
(xxiv)EUR 20000 for Sweden.’;
(c)in paragraph 3, points (a) to (f) are replaced by the following:‘(a)for an ELISA testEUR 3 per test;(b)for a PCR testEUR 12 per test;(c)for the purchase of monovalent vaccinesEUR 0,36 per dose;(d)for the purchase of bivalent vaccinesEUR 0,54 per dose;(e)for the administration of vaccines to bovine animalsEUR 1,80 per bovine animal vaccinated, regardless of the number and types of doses used;(f)for the administration of vaccines to ovine or caprine animalsEUR 0,90 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.’;
(a)in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b)paragraph 2(c) is replaced by the following:
(c)shall not exceed the following:
(i)EUR 1200000 for Belgium;
(ii)EUR 25000 for Bulgaria;
(iii)EUR 2100000 for the Czech Republic;
(iv)EUR 340000 for Denmark;
(v)EUR 1000000 for Germany;
(vi)EUR 40000 for Estonia;
(vii)EUR 120000 for Ireland;
(viii)EUR 1000000 for Greece;
(ix)EUR 1300000 for Spain;
(x)EUR 660000 for France;
(xi)EUR 1700000 for Italy;
(xii)EUR 150000 for Cyprus;
(xiii)EUR 1650000 for Latvia;
(xiv)EUR 20000 for Luxembourg;
(xv)EUR 2400000 for Hungary;
(xvi)EUR 150000 for Malta;
(xvii)EUR 3900000 for the Netherlands;
(xviii)EUR 1200000 for Austria;
(xix)EUR 4800000 for Poland;
(xx)EUR 65000 for Portugal;
(xxi)EUR 500000 for Romania;
(xxii)EUR 120000 for Slovenia;
(xxiii)EUR 600000 for Slovakia;
(xxiv)EUR 75000 for the United Kingdom.’;
(c)in paragraph 3, points (a) to (e) are replaced by the following:‘(a)for a bacteriological test (cultivation/isolation)EUR 8,4 per test;(b)for the purchase of vaccineEUR 0,06 per dose;(c)for serotyping of relevant isolates of Salmonella spp.EUR 24 per test;(d)for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a salmonella-positive flockEUR 6 per test;(e)for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonellaEUR 6 per test.’;
(a)in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b)paragraph 2(c) is replaced by the following:
(c)shall not exceed the following:
(i)EUR 90000 for Belgium;
(ii)EUR 25000 for Bulgaria;
(iii)EUR 70000 for the Czech Republic;
(iv)EUR 80000 for Denmark;
(v)EUR 300000 for Germany;
(vi)EUR 10000 for Estonia;
(vii)EUR 75000 for Ireland;
(viii)EUR 50000 for Greece;
(ix)EUR 150000 for Spain;
(x)EUR 150000 for France;
(xi)EUR 1000000 for Italy;
(xii)EUR 20000 for Cyprus;
(xiii)EUR 45000 for Latvia;
(xiv)EUR 10000 for Lithuania;
(xv)EUR 10000 for Luxembourg;
(xvi)EUR 360000 for Hungary
(xvii)EUR 20000 for Malta;
(xviii)EUR 360000 for the Netherlands;
(xix)EUR 60000 for Austria;
(xx)EUR 100000 for Poland;
(xxi)EUR 45000 for Portugal;
(xxii)EUR 180000 for Romania;
(xxiii)EUR 50000 for Slovenia;
(xxiv)EUR 15000 for Slovakia;
(xxv)EUR 25000 for Finland;
(xxvi)EUR 50000 for Sweden;
(xxvii)EUR 160000 for the United Kingdom.’;
(c)in paragraph 3, points (a) to (e) are replaced by the following:‘(a)ELISA testEUR 2,4 per test;(b)agar gel immune diffusion testEUR 1,44 per test;(c)HI test for H5/H7EUR 14,40 per test;(d)virus isolation testEUR 48 per test;(e)PCR testEUR 24 per test.’;